Status:

COMPLETED

Effects of Respiratory Muscle Functions on Interstitial Lung Disease: Sleep Quality, Dyspnea, and Fatigue

Lead Sponsor:

Istanbul University

Collaborating Sponsors:

TURK TORAKS DERNEGI

Conditions:

Interstitial Lung Disease

Eligibility:

All Genders

18-70 years

Brief Summary

Although there are numerous data demonstrating the impact of Interstitial Lung Disease (ILD) on respiratory functions, there is a lack of studies investigating the effects of respiratory functions on ...

Detailed Description

Introduction: Despite having numerous data demonstrating the impact of Interstitial Airway Disease (IAD) on respiratory functions, there is a lack of studies investigating the effects of respiratory f...

Eligibility Criteria

Inclusion

  • Being 18 years of age or older.
  • Having a diagnosis of Interstitial Lung Disease (ILD) by a chest diseases specialist.

Exclusion

  • Systemic involvement of ILD
  • Cooperation problem
  • Presence of orthopedic/neurological issues hindering walking and exercise.
  • Uncontrolled cardiovascular disease.
  • Presence of acute upper and lower respiratory tract infections.

Key Trial Info

Start Date :

June 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2023

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT05993520

Start Date

June 1 2020

End Date

June 1 2023

Last Update

August 16 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

İstanbul Üniversitesi-Cerrahpaşa

Istanbul, Buyucekmece, Turkey (Türkiye)